Study identifies best treatment for rare childhood cancer
Dr Martin McCabe presented the results of the rEECur study into recurrent and primary refractory Ewing sarcoma at the 2022 American Society of Clinical Oncology
The ALETHEIA framework in radiation oncology
Dr Marianne Aznar explains the ALETHEIA Framework, an AI toolkit developed by Rolls-Royce, and how…
Cancer researchers across the UK…
DETERMINE is the first UK national precision medicine trial in rare cancers, testing a range…
Research on detecting cancer in…
Review suggests best ways to treat to reoccurring prostate cancer
The review funded by Cancer Research UK, in which academics at the Universities of Manchester…
NCITA comment article published in…
Women’s stronger immune response could…
Women may have a stronger immune response to a common form of skin cancer than…
Scientists reveal how common anti-inflammatory…
First proton beam therapy clinical trial in the UK
The first proton beam therapy clinical trial in the UK is now taking place at…
Critical step forward for radiotherapy…
Simple urine test can detect womb cancer
A simple non-invasive test can accurately detect womb cancer according to a proof of concept study by…
Shorter radiotherapy course reduces risk…
Ultraviolet radiation causes rare type…
Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma, according to University…
‘First of its kind’ clinical…
A group of scientists across Newcastle, Leeds, Manchester and Glasgow have been awarded £900,000 from…
